ÂÜÀòÂÒÂ×

Mark Howansky is an accomplished professional with extensive experience in device development and commercialization within the medical device industry. Currently serving as Vice President of Device Development and Commercialization at Viridian Therapeutics, Inc., Mark leads efforts in developing combination products and drug delivery systems, collaborating with technology firms for Health Authority approvals. Previous roles include Director and Associate Director of Device Development at Bristol Myers Squibb, where Mark managed teams to support drug delivery technologies, and Director of Engineering at Caliber Therapeutics, focusing on minimally-invasive solutions for atherosclerotic diseases. Mark's career also includes significant contributions at Ethicon, Inc., Stryker Orthopaedics, and Cardio Technologies, with a strong foundation in engineering and business, holding multiple degrees from prestigious institutions, including Harvard University and NYU Stern School of Business.